4 min listen
Coronapod: new hope from COVID antiviral drugs
FromNature Podcast
ratings:
Length:
18 minutes
Released:
Nov 12, 2021
Format:
Podcast episode
Description
Two new anti-viral pills have been shown to be safe and effective against COVID in clinical trials, according to recent press releases. The drugs, molnupiravir, developed by Merck and Ridgeback Biotherapeutics, and Paxlovid, developed by Pfizer both appear to significantly reduce hospitalisation in people with early COVID. Some researchers are quietly hopeful that these new weapons in the anti-COVID arsenal could have a big impact, in particular in parts of the world where vaccines are still not widely available, but there are a number of caveats. In this episode of Coronapod, we open the pill boxes and pick through the contents - asking how the drugs work, what side effects we might see and how, if at all, they might change the course of the pandemic.News: COVID antiviral pills: what scientists still want to knowSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
See acast.com/privacy for privacy and opt-out information.
See acast.com/privacy for privacy and opt-out information.
Released:
Nov 12, 2021
Format:
Podcast episode
Titles in the series (100)
Nature Podcast Extra: Futures: Futures is Nature's weekly science fiction slot. Now its sister title Nature Physics has followed suit, publishing a sci-fi story each month. Kerri Smith reads you this month’s tale, The stuff we don’t do, by Marissa Lingen. by Nature Podcast